In vivo And NotF. Calon
List of bibliographic references
Number of relevant bibliographic references: 21.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 000440 | Fanny Schmiijt [France] ; Gael Le Douaron [France] ; Pierre Champy [France] ; Majid Amar [France] ; Blandine Seon-Meniel [France] ; Rita Raisman-Vozari [France] ; Bruno Figadere [France] | Tryptamine-derived alkaloids from Annonaceae exerting neurotrophin-like properties on primary dopaminergic neurons |
| 000590 | Aymeric Chartier [France] ; Vered Raz [Pays-Bas] ; Ellen Sterrenburg [Pays-Bas] ; C. Theo Verrips [Pays-Bas] ; Silvère M. Van Der Maarel [Pays-Bas] ; Martine Simonelig [France] | Prevention of oculopharyngeal muscular dystrophy by muscular expression of Llama single-chain intrabodies in vivo |
| 000592 | S. Bourgault [Canada, France] ; D. Vaudry [France] ; A. Dejda [Canada, France] ; N. D. Doan [Canada, France] ; H. Vaudry [France] ; A. Fournier [Canada, France] | Pituitary Adenylate Cyclase-Activating Polypeptide: Focus on Structure-Activity Relationships of a Neuroprotective Peptide |
| 000772 | Stéphane Woerly [France] ; Sébastien Fort [France] ; Isabelle Pignot-Paintrand [France] ; Cécile Cottet [France] ; Carole Carcenac [France] ; Marc Savasta [France] | Development of a Sialic Acid-Containing Hydrogel of Poly[N-(2-hydroxypropyl) methacrylamide] : Characterization and Implantation Study |
| 000845 | Pauline Sibille [France] ; Sébastien Lopez [France] ; Isabelle Brabet [France] ; Omella Valenti [États-Unis] ; Nadia Oueslati [France] ; Florence Gaven [France] ; Cyril Goudet [France] ; Hugues-Olivier Bertrand [France] ; Jacques Neyton [France] ; Michael J. Marino [États-Unis] ; Marianne Amalric [France] ; Jean-Philippe Pin [France] ; Francine C. Acher [France] | Synthesis and biological evaluation of 1 -amino -2 -phosphonomethylcyclopropanecarboxylic acids, new group III metabotropic glutamate receptor agonists |
| 000918 | Fabrice Guillemot [France] ; Italina Cerutti [France] ; Charles Auffray [France] ; Marie-Dominique Devignes [France] | A transgenic mouse model engineered to investigate human brain-derived neurotrophic factor in vivo |
| 000F56 | Yoshimi Misu [Japon] ; Nobuya Furukawa [Japon] ; Nobutaka Arai [Japon] ; Takeaki Miyamae [Japon] ; Yoshio Goshima [Japon] ; Kiyohide Fujita [Japon] | DOPA causes glutamate release and delayed neuron death by brain ischemia in rats |
| 000F73 | A. Nicotra [Italie] ; S. H. Parvez [France] | Apoptotic molecules and MPTP-induced cell death |
| 001190 | Patrice Mayer [France] ; Pascale Brunel [France] ; Céline Chaplain [France] ; Christel Piedecoq [France] ; Francis Calmel [France] ; Philippe Schambel [France] ; Philippe Chopin [France] ; Thierry Wurch [France] ; Petrus J. Pauwels [France] ; Marc Marien [France] ; Jean-Louis Vidaluc [France] ; Thierry Imbert [France] | New substituted 1-(2,3-dihydrobenzo[1,4]dioxin-2-ylmethyl)piperidin-4-yl derivatives with α2-Adrenoceptor antagonist activity |
| 001206 | P. Missy [France] ; M-C Lanhers [France] ; Y. Grignon [France] ; M. Joyeux [France] ; D. Burnel [France] | In vitro and in vivo studies on chelation of manganese |
| 001326 | M. G. Murer [Argentine] ; R. Raisman-Vozari [France] ; O. Gershanik [Argentine] | Levodopa in Parkinson's disease : Neurotoxicity issue laid to rest? |
| 001351 | F. A. Dajas-Bailador [Uruguay] ; M. Asencio [Chili] ; C. Bonilla [Uruguay] ; M. C. Scorza [Uruguay] ; C. Echeverry [Uruguay] ; M. Reyes-Parada [Uruguay] ; R. Silveira [Uruguay] ; P. Protais [France] ; G. Russell [Nouvelle-Zélande] ; B. K. Cassels [Chili] ; F. Dajas [Uruguay] | Dopaminergic pharmacology and antioxidant properties of pukateine, a natural product lead for the design of agents increasing dopamine neurotransmission |
| 001377 | Synthèse de radioligands marqués au brome-76 et au carbone-11 pour l'étude des récepteurs N-Méthyl-D-Aspartate par Tomographie d'Emission de Positons | |
| 001580 | L. J. Anghileri [France] ; P. Thouvenot [France] ; A. Bertrand [France] | Effects of iron complexes on brain calcium homeostasis |
| 001603 | Synthèse et pharmacologie de nouveaux inhibiteurs de la monoamine oxydase B | |
| 001612 | F. Tranquart [France] ; C. Prunier-Levillion [France] ; D. Guilloteau [France] ; B. De Toffol [France] ; A. Autret [France] ; J. C. Besnard [France] ; J. L. Baulieu [France] | Tomoscintigraphie cérébrale à l'iodobenzamide en pathologie neuropsychiatrique : technique et pertinence clinique |
| 001678 | Utilisation et amélioration de l'adénovirus en tant que vecteur viral pour le tranfert de gènes | |
| 001705 | L. Lebreton [France] ; O. Curet [France] ; S. Gueddari [France] ; FATHI MAZOUZ [France] ; S. Bernard [France] ; C. Burstein [France] ; R. Milcent [France] | Selective and potent monoamine oxidase type B inhibitors : 2-substituted 5-aryltetrazole derivatives |
| 001807 | P. Horellou [France] ; E. Vigne [France] ; M.-N. Castel [France] ; P. Barneoud [France] ; P. Colin [France] ; M. Perricaudet [France] ; P. Delaere [France] ; J. Mallet [France] | Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease |
| 001957 | L. J. Anghileri [France] | Effects of complexes iron and aluminium on brain calcium |
| 001B83 | P. Hantraye ; C. Loc'H ; U. Tacke ; D. Riche ; O. Stulzaft ; D. Doudet ; B. Guibert ; R. Naquet ; B. Maziere ; M. Maziere | "In vivö visualization by positron emission tomography of the progressive striatal dopamine receptor damage occurring in MPTP-intoxicated non-human primates |
| This area was generated with Dilib version V0.6.29. |  |